FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer - Prabadin Corp

https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer

Drug Test

November 19, 2025

By AdminPrabadin - 9 months ago

0

On November 19, 2025, the Food and Drug Administration granted accelerated approval to sevabertinib.

administrator